within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC04_Clopidogrel;

model Clopidogrel
  extends Pharmacolibrary.Drugs.ATC.B.B01AC04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B01AC04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Clopidogrel is an oral antiplatelet agent that inhibits ADP-induced platelet aggregation by antagonizing the P2Y12 receptor. It is used to prevent atherothrombotic events in patients with myocardial infarction, stroke, or established peripheral arterial disease. Clopidogrel is currently approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult male and female volunteers receiving a single 75 mg oral dose of clopidogrel.</p><h4>References</h4><ol><li><p>Gelbenegger, G, &amp; Jilma, B (2022). Clinical pharmacology of antiplatelet drugs. <i>Expert review of clinical pharmacology</i> 15(10) 1177–1197. DOI:<a href=&quot;https://doi.org/10.1080/17512433.2022.2121702&quot;>10.1080/17512433.2022.2121702</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36065676/&quot;>https://pubmed.ncbi.nlm.nih.gov/36065676</a></p></li><li><p>Caplain, H, et al., &amp; Necciari, J (1999). Pharmacokinetics of clopidogrel. <i>Seminars in thrombosis and hemostasis</i> 25 Suppl 2 25–28. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10440419/&quot;>https://pubmed.ncbi.nlm.nih.gov/10440419</a></p></li><li><p>Norris, JW, et al., &amp; Knych, HK (2019). Pharmacokinetics and competitive pharmacodynamics of ADP-induced platelet activation after oral administration of clopidogrel to horses. <i>American journal of veterinary research</i> 80(5) 505–512. DOI:<a href=&quot;https://doi.org/10.2460/ajvr.80.5.505&quot;>10.2460/ajvr.80.5.505</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31034271/&quot;>https://pubmed.ncbi.nlm.nih.gov/31034271</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Clopidogrel;
